Found: 83
Select item for more details and to access through your institution.
Expression of tumor antigens within an oncolytic virus enhances the anti-tumor T cell response.
- Published in:
- Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-49286-x
- By:
- Publication type:
- Article
Current Status and Challenges of Oncolytic Virotherapy for the Treatment of Glioblastoma.
- Published in:
- Pharmaceuticals (14248247), 2023, v. 16, n. 6, p. 793, doi. 10.3390/ph16060793
- By:
- Publication type:
- Article
Route of self-amplifying mRNA vaccination modulates the establishment of pulmonary resident memory CD8 and CD4 T cells.
- Published in:
- Science Immunology, 2022, v. 7, n. 78, p. 1, doi. 10.1126/sciimmunol.add3075
- By:
- Publication type:
- Article
Systems neuroimmunology: a review of multiomics methodologies to characterize neuroimmunological interactions in spinal and cranial diseases.
- Published in:
- Neurosurgical Focus, 2022, v. 52, n. 2, p. 1, doi. 10.3171/2021.11.FOCUS21571
- By:
- Publication type:
- Article
Phase I trial of sargramostim/pelareorep therapy in pediatric patients with recurrent or refractory high-grade brain tumors.
- Published in:
- Neuro-Oncology Advances, 2022, v. 4, n. 1, p. 1, doi. 10.1093/noajnl/vdac085
- By:
- Publication type:
- Article
Inactivation of Replication-Competent Vesicular Stomatitis Virus as SARS-CoV-2 Surrogate on Common Surfaces by Disinfectants.
- Published in:
- International Journal of Environmental Research & Public Health, 2021, v. 18, n. 14, p. 7714, doi. 10.3390/ijerph18147714
- By:
- Publication type:
- Article
Modular network mechanism of CCN1-associated resistance to HSV-1-derived oncolytic immunovirotherapies for glioblastomas.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-90718-1
- By:
- Publication type:
- Article
Parking CAR T Cells in Tumours: Oncolytic Viruses as Valets or Vandals?
- Published in:
- Cancers, 2021, v. 13, n. 5, p. 1106, doi. 10.3390/cancers13051106
- By:
- Publication type:
- Article
Synthetic and systems biology principles in the design of programmable oncolytic virus immunotherapies for glioblastoma.
- Published in:
- Neurosurgical Focus, 2021, v. 50, n. 2, p. 1, doi. 10.3171/2020.12.FOCUS20855
- By:
- Publication type:
- Article
Brain cancer induces systemic immunosuppression through release of non-steroid soluble mediators.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Ad-CD40L mobilizes CD4 T cells for the treatment of brainstem tumors.
- Published in:
- Neuro-Oncology, 2020, v. 22, n. 12, p. 1757, doi. 10.1093/neuonc/noaa126
- By:
- Publication type:
- Article
Oncolytic virus-derived type I interferon restricts CAR T cell therapy.
- Published in:
- Nature Communications, 2020, v. 11, n. 1, p. N.PAG, doi. 10.1038/s41467-020-17011-z
- By:
- Publication type:
- Article
Oncolytic virus-derived type I interferon restricts CAR T cell therapy.
- Published in:
- Nature Communications, 2020, v. 11, n. 1, p. 1, doi. 10.1038/s41467-020-17011-z
- By:
- Publication type:
- Article
APOBEC3B-mediated corruption of the tumor cell immunopeptidome induces heteroclitic neoepitopes for cancer immunotherapy.
- Published in:
- Nature Communications, 2020, v. 11, n. 1, p. 1, doi. 10.1038/s41467-020-14568-7
- By:
- Publication type:
- Article
Genetically modified lentiviruses that preserve microvascular function protect against late radiation damage in normal tissues.
- Published in:
- Science Translational Medicine, 2018, v. 10, n. 425, p. 1, doi. 10.1126/scitranslmed.aar2041
- By:
- Publication type:
- Article
Sickle Cells Abolish Melanoma Tumorigenesis in Hemoglobin SS Knockin Mice and Augment the Tumoricidal Effect of Oncolytic Virus In Vivo.
- Published in:
- Frontiers in Oncology, 2016, p. 1, doi. 10.3389/fonc.2016.00166
- By:
- Publication type:
- Article
Combination viroimmunotherapy with checkpoint inhibition to treat glioma, based on location-specific tumor profiling.
- Published in:
- Neuro-Oncology, 2016, v. 18, n. 4, p. 518, doi. 10.1093/neuonc/nov173
- By:
- Publication type:
- Article
Harnessing the Power of Onco-Immunotherapy with Checkpoint Inhibitors.
- Published in:
- Viruses (1999-4915), 2015, v. 7, n. 11, p. 5889, doi. 10.3390/v7112914
- By:
- Publication type:
- Article
Mutated BRAF Emerges as a Major Effector of Recurrence in a Murine Melanoma Model After Treatment With Immunomodulatory Agents.
- Published in:
- Molecular Therapy, 2015, v. 23, n. 5, p. 845, doi. 10.1038/mt.2014.253
- By:
- Publication type:
- Article
BRAF- and MEK-Targeted Small Molecule Inhibitors Exert Enhanced Antimelanoma Effects in Combination With Oncolytic Reovirus Through ER Stress.
- Published in:
- Molecular Therapy, 2015, v. 23, n. 5, p. 931, doi. 10.1038/mt.2015.15
- By:
- Publication type:
- Article
How To Train Your Oncolytic Virus: the Immunological Sequel.
- Published in:
- Molecular Therapy, 2014, v. 22, n. 11, p. 1881, doi. 10.1038/mt.2014.188
- By:
- Publication type:
- Article
The Profile of Tumor Antigens Which Can be Targeted by Immunotherapy Depends Upon the Tumor's Anatomical Site.
- Published in:
- Molecular Therapy, 2014, v. 22, n. 11, p. 1936, doi. 10.1038/mt.2014.134
- By:
- Publication type:
- Article
Cytokine Conditioning Enhances Systemic Delivery and Therapy of an Oncolytic Virus.
- Published in:
- Molecular Therapy, 2014, v. 22, n. 10, p. 1851, doi. 10.1038/mt.2014.118
- By:
- Publication type:
- Article
Les tumeurs dormantes prises au piège de la récidive.
- Published in:
- Médecine Sciences, 2014, v. 30, n. 4, p. 355, doi. 10.1051/medsci/20143004006
- By:
- Publication type:
- Article
Detecting and targeting tumor relapse by its resistance to innate effectors at early recurrence.
- Published in:
- Nature Medicine, 2013, v. 19, n. 12, p. 1625, doi. 10.1038/nm.3397
- By:
- Publication type:
- Article
Functional Cloning of Recurrence-specific Antigens Identifies Molecular Targets to Treat Tumor Relapse.
- Published in:
- Molecular Therapy, 2013, v. 21, n. 8, p. 1507, doi. 10.1038/mt.2013.116
- By:
- Publication type:
- Article
Cytotoxic and immune-mediated killing of human colorectal cancer by reovirus-loaded blood and liver mononuclear cells.
- Published in:
- International Journal of Cancer, 2013, v. 132, n. 10, p. 2327, doi. 10.1002/ijc.27918
- By:
- Publication type:
- Article
The Efficacy Versus Toxicity Profile of Combination Virotherapy and TLR Immunotherapy Highlights the Danger of Administering TLR Agonists to Oncolytic Virus-treated Mice.
- Published in:
- Molecular Therapy, 2013, v. 21, n. 2, p. 348, doi. 10.1038/mt.2012.204
- By:
- Publication type:
- Article
Phase II Trial of Intravenous Administration of Reolysin<sup>®</sup> (Reovirus Serotype-3-dearing Strain) in Patients with Metastatic Melanoma.
- Published in:
- Molecular Therapy, 2012, v. 20, n. 10, p. 1998, doi. 10.1038/mt.2012.146
- By:
- Publication type:
- Article
Broad antigenic coverage induced by vaccination with virus-based cDNA libraries cures established tumors.
- Published in:
- Nature Medicine, 2012, v. 18, n. 9, p. 1445, doi. 10.1038/nm0912-1445d
- By:
- Publication type:
- Article
Adoptive T cell therapy promotes the emergence of genomically altered tumor escape variants.
- Published in:
- International Journal of Cancer, 2012, v. 131, n. 4, p. 844, doi. 10.1002/ijc.26447
- By:
- Publication type:
- Article
Using virally expressed melanoma cDNA libraries to identify tumor-associated antigens that cure melanoma.
- Published in:
- Nature Biotechnology, 2012, v. 30, n. 4, p. 337, doi. 10.1038/nbt.2157
- By:
- Publication type:
- Article
Reovirus exerts potent oncolytic effects in head and neck cancer cell lines that are independent of signalling in the EGFR pathway.
- Published in:
- BMC Cancer, 2012, v. 12, n. 1, p. 368, doi. 10.1186/1471-2407-12-368
- By:
- Publication type:
- Article
An Intravenous Stimulus Package for Oncolytic Virotherapy.
- Published in:
- Molecular Therapy, 2011, v. 19, n. 11, p. 1930, doi. 10.1038/mt.2011.217
- By:
- Publication type:
- Article
Precise Scheduling of Chemotherapy Primes VEGF-producing Tumors for Successful Systemic Oncolytic Virotherapy.
- Published in:
- Molecular Therapy, 2011, v. 19, n. 10, p. 1802, doi. 10.1038/mt.2011.147
- By:
- Publication type:
- Article
Synergistic effects of oncolytic reovirus and docetaxel chemotherapy in prostate cancer.
- Published in:
- BMC Cancer, 2011, v. 11, n. 1, p. 221, doi. 10.1186/1471-2407-11-221
- By:
- Publication type:
- Article
Pro-inflammatory cytokine/chemokine production by reovirus treated melanoma cells is PKR/NF-κB mediated and supports innate and adaptive anti-tumour immune priming.
- Published in:
- Molecular Cancer, 2011, v. 10, n. 1, p. 20, doi. 10.1186/1476-4598-10-20
- By:
- Publication type:
- Article
Vesicular Stomatitis Virus-induced Immune Suppressor Cells Generate Antagonism Between Intratumoral Oncolytic Virus and Cyclophosphamide.
- Published in:
- Molecular Therapy, 2011, v. 19, n. 1, p. 140, doi. 10.1038/mt.2010.224
- By:
- Publication type:
- Article
VSV Oncolytic Virotherapy in the B16 Model Depends Upon Intact MyD88 Signaling.
- Published in:
- Molecular Therapy, 2011, v. 19, n. 1, p. 150, doi. 10.1038/mt.2010.225
- By:
- Publication type:
- Article
The Effect of Cell Cycle Synchronization on Tumor Sensitivity to Reovirus Oncolysis.
- Published in:
- Molecular Therapy, 2010, v. 18, n. 12, p. 2085, doi. 10.1038/mt.2010.189
- By:
- Publication type:
- Article
Therapeutic Effect of Sodium Iodide Symporter Gene Therapy Combined With External Beam Radiotherapy and Targeted Drugs That Inhibit DNA Repair.
- Published in:
- Molecular Therapy, 2010, v. 18, n. 9, p. 1599, doi. 10.1038/mt.2010.120
- By:
- Publication type:
- Article
Antiangiogenic cancer therapy combined with oncolytic virotherapy leads to regression of established tumors in mice.
- Published in:
- 2010
- By:
- Publication type:
- journal article
Oncolytic Viruses: Now Interviewing for the All-Star Game.
- Published in:
- 2010
- By:
- Publication type:
- Opinion
Immunology and Gene Therapy: Shoulder to Shoulder Into the Fray.
- Published in:
- 2010
- By:
- Publication type:
- Proceeding
Cell Carriers for Oncolytic Viruses: Fed Ex for Cancer Therapy.
- Published in:
- Molecular Therapy, 2009, v. 17, n. 10, p. 1667, doi. 10.1038/mt.2009.194
- By:
- Publication type:
- Article
5th International Meeting on Replicating Oncolytic Virus Therapeutics Banff, Alberta, Canada, 18–22 March 2009.
- Published in:
- 2009
- By:
- Publication type:
- Proceeding
Use of Biological Therapy to Enhance Both Virotherapy and Adoptive T-Cell Therapy for Cancer.
- Published in:
- Molecular Therapy, 2008, v. 16, n. 12, p. 1910, doi. 10.1038/mt.2008.212
- By:
- Publication type:
- Article
Treg Depletion–enhanced IL-2 Treatment Facilitates Therapy of Established Tumors Using Systemically Delivered Oncolytic Virus.
- Published in:
- Molecular Therapy, 2008, v. 16, n. 7, p. 1217, doi. 10.1038/mt.2008.83
- By:
- Publication type:
- Article
Autologous versus allogeneic peptide-pulsed dendritic cells for anti-tumour vaccination: expression of allogeneic MHC supports activation of antigen specific T cells, but impairs early naïve cytotoxic priming and anti-tumour therapy.
- Published in:
- Cancer Immunology, Immunotherapy, 2008, v. 57, n. 6, p. 897, doi. 10.1007/s00262-007-0426-9
- By:
- Publication type:
- Article
Purging metastases in lymphoid organs using a combination of antigen-nonspecific adoptive T cell therapy, oncolytic virotherapy and immunotherapy.
- Published in:
- Nature Medicine, 2008, v. 14, n. 1, p. 37, doi. 10.1038/nm1681
- By:
- Publication type:
- Article